 Fulcrum Therapeutics, Inc. NASDAQ:FULC Q2 2022 Earnings Conference Call August 11, 2022 8:00 AM ET Company Participants Stephanie Ascher - Stern, Investor Relations Bryan Stuart - President Chief Executive Officer Judy Dunn - President, Research Development Esther Rajavelu - Chief Financial Officer Paul Bruno - Executive Director, Corporate Development Conference Call Participants Judah Frommer - Credit Suisse Ted Tenthoff - Piper Sandler Dae Gon Ha - Stifel Matt Biegler - Oppenheimer Joseph Schwartz - SVB Yatin Suneja - Guggenheim Operator Good morning, and welcome to the Fulcrum Therapeutics Second Quarter 2022 Conference Call. Currently all participants are in a listen-only mode. 